India Joint Replacement - Market Size, Procedure Volume, Growth Trend at City, State and National Level
India Coronary Stent Market to be Tripled by 2021
- No one has covered cath labs in India like us: ABMRG
- Primary research covering 700 angioplasty centres in 150 cities
- Comparative analysis among states & regions; hospital chains; govt & pvt hospitals
The coronary stent market in India, which comprises Drug Eluting Stent (DES), Bare Metal Stent (BMS) and Bio-Absorbable Stent (BVS), was valued above $400 million in 2012. DES accounts for bulk of sales in India. The bio-absorbable stent ABSORB has garnered a considerable traction despite its high cost compared with the other available DES. The key players operating in the segment are Alvimedica,
Abbott Vascular, a division of Abbott Laboratories (NYSE : ABT), Boston Scientific (NYSE : BSX, LSE : BSX), Biosensors Inc., Biotronik, JW Medical, Medtronic, Inc. (NYSE :MDT), Meril Life Sciences, MicroPort Scientific Corporation (HKG: 0853), Sahajanand Medical Technologies and Translumina Therapeutics.
The market has grown impressively supported by a rise in coronary angioplasties which has resulted from a surge in cardiovascular diseases (CVDs), augmented healthcare spending as well as an increase in number of interventional cardiologists and cath labs in government and private hospitals, including individual cath lab centres run by interventional cardiologists as well as new corporate hospitals.
- Please Note: Due to the brevity and/or nature of the content posted, there is no table of contents available for this report.